NewsBenzingaLa FDA aprueba talazoparib con enzalutamida para el cáncer de próstata metastásico con mutaciones en genes HRR, naïve o sensible a la modulación de la vía androgénica La FDA aprueba talazoparib con enzalutamida para el cáncer de próstata metastásico con mutaciones en genes HRR, naïve o sensible a la modulación de la vía androgénica Benzinga 2026.10.26 16:46 (GMT+0) Open on Benzinga Other news Why Is Salesforce Stock Falling on Wednesday? This Elevance Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday Ford Ships First Battery Cells from Michigan Plant for Fathom Electric Pickup; Key Milestone for Ford Energy Bill Ackman Says Believes Board Not Acting In Best Interest Of Shareholders Nor In A Manner Consistent With Their Fiduciary Duties; Should Have Slept On Decision To Replace Jensen Huang And Met Again The Day After To Discuss The Facts Crude Oil Down Over 4%; Target Earnings Top Views BellRing Brands Beats Q4 Revenue Estimates, Announces New CFO
Ford Ships First Battery Cells from Michigan Plant for Fathom Electric Pickup; Key Milestone for Ford Energy
Bill Ackman Says Believes Board Not Acting In Best Interest Of Shareholders Nor In A Manner Consistent With Their Fiduciary Duties; Should Have Slept On Decision To Replace Jensen Huang And Met Again The Day After To Discuss The Facts